Modulation of the frequency of human cytomegalovirus-induced chromosome aberrations by camptothecin

Virology. 1992 Jul;189(1):397-401. doi: 10.1016/0042-6822(92)90724-4.

Abstract

The effects of selected DNA repair inhibitors on the frequency of human cytomegalovirus (HCMV)-induced chromosome aberrations were evaluated in human peripheral blood lymphocytes (PBLs). Treatment of HCMV-infected PBLs with camptothecin (0.05 to 0.3 micrograms/ml), an inhibitor of topoisomerase I, for 30 hr resulted in a significant (P less than 0.01) synergistic enhancement of the frequency of HCMV-induced chromosome damage. On the other hand, a significant increase in the frequency of chromosome damage was not noted for infected PBLs treated with either 3-aminobenzamide (3-AB; 3 to 30 micrograms/ml), an inhibitor of poly(ADP-ribose) polymerase, or novobiocin (3 to 30 micrograms/ml), an inhibitor of topoisomerase II or excision repair processes, for 30 hr. Chromatid-type breaks and exchanges were the predominant type of chromosome aberrations observed in the HCMV-infected cells treated with camptothecin, suggesting that HCMV infection is associated with the induction of single-strand DNA breaks. Furthermore, these findings suggest that HCMV infection does not inflict direct DNA damage which is repaired through 3-AB- or novobiocin-sensitive pathways.

Publication types

  • Research Support, Non-U.S. Gov't
  • Research Support, U.S. Gov't, Non-P.H.S.

MeSH terms

  • Benzamides / pharmacology
  • Camptothecin / pharmacology*
  • Cells, Cultured
  • Chromosome Aberrations / physiology*
  • Cytomegalovirus Infections / genetics
  • Cytomegalovirus Infections / metabolism*
  • DNA Repair / drug effects*
  • Dose-Response Relationship, Drug
  • Humans
  • Lymphocytes / drug effects*
  • Lymphocytes / microbiology
  • Novobiocin / pharmacology
  • Poly(ADP-ribose) Polymerase Inhibitors

Substances

  • Benzamides
  • Poly(ADP-ribose) Polymerase Inhibitors
  • Novobiocin
  • 3-aminobenzamide
  • Camptothecin